Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 151-159

  Jutkiewicz, Emily M ^a   Torregrossa, Mary M ^e   Sobczyk Kojiro, Katarzyna ^b   Mosberg, Henry I ^b   Folk, John E ^d   Rice, Kenner C ^d   Watson, Stanley J ^c   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

(Rat); Behavior; Brain derived neurotrophic factor; Forced swim test; RB101

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DELTA OPIATE RECEPTOR; ENKEPHALINASE INHIBITOR; MESSENGER RNA; N [3 [(2 AMINO 4 METHYLTHIO)BUTYLDITHIO] 2 BENZYLPROPIONYL]PHENYLALANINE BENZYL ESTER; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; FORCED SWIMMING TEST; GENE EXPRESSION; LOCOMOTION; MALE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZAMIDES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISULFIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ENZYME INHIBITORS; FRONTAL LOBE; HIPPOCAMPUS; INJECTIONS, INTRAVENOUS; MALE; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; NEPRILYSIN; PHENYLALANINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SWIMMING;

EID: 32044471515     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.002     Document Type: Article

References (34)

1. A. Baamonde, V. Daugé, M. Ruiz-Gayo, I.G. Fulga, S. Turcaud, M.C. Fournié-Zaluski, and B.P. Roques Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation Eur. J. Pharmacol. 216 1992 157 166
2. T.J. Baird, S.X. Deng, D.W. Landry, G. Winger, and J.H. Woods Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats J. Pharmacol. Exp. Ther. 295 2000 1127 1134
3. D.C. Broom, E.M. Jutkiewicz, J.E. Folk, J.R. Traynor, K.C. Rice, and J.H. Woods Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats Neuropsychopharmacology 26 2002 744 755
4. S.N. Calderon, R.B. Rothman, F. Porreca, J.L. Flippen-Anderson, R.W. McNutt, H. Xu, L.E. Smith, E.J. Bilsky, P. Davis, and K.C. Rice Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(αR)- α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC80): a highly selective, nonpeptide delta opioid receptor agonist J. Med. Chem. 37 1994 2125 2128
5. S.D. Comer, E.M. Hoenicke, A.I. Sable, R.W. McNutt, K.J. Chang, B.R. De Costa, H.I. Mosberg, and J.H. Woods Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice J. Pharmacol. Exp. Ther. 267 1993 888 895
6. V. Daugé, A. Mauborgne, F. Cesselin, M.C. Fournié-Zaluski, and B.P. Roques The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular levels of met-enkephalin-like material in the nucleus accumbens of freely moving rats J. Neurochem. 67 1996 1301 1308
7. G.B. De Sarro, R. Marra, C. Spagnolo, and G. Nisticò Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats Funct. Neurology 3 1992 235 238
8. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology 121 1995 66 72
9. R.S. Duman Synaptic plasticity and mood disorders Mol. Psychiatry 7 2002 S29 S34
10. L.A. Dykstra, G.M. Schoenbaum, J. Yarbrough, R. McNutt, and K.J. Chang A novel δ-opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration J. Pharmacol. Exp. Ther. 267 1993 875 882
11. J. Haffmans, and M.R. Dzoljic Differential epileptogenic potentials of selective μ and δ opiate receptor agonists J. Neural Transm. 57 1983 1 11
12. A.C. Hansson, W. Sommer, R. Rimondini, B. Andbjer, I. Stromberg, and K. Fuxe C-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region J. Neurosci. 23 2003 6013 6022
13. E.J. Hong, K.C. Rice, S. Calderon, J.H. Woods, and J.R. Traynor Convulsive behavior of nonpeptide δ-opioid ligands: comparison of SNC80 and BW373U86 in mice Analgesia 3 1998 269 276
14. H. Houshyar, Z.D. Cooper, and J.H. Woods Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal response to acute restraint stress paradigm J. Neuroendocrinol. 13 2001 862 874
15. P.J. Isackson, M.M. Huntsman, K.D. Murray, and C.M. Gall BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF Neuron 6 1991 937 948
16. E.M. Jutkiewicz, E.B. Eller, J.E. Folk, K.C. Rice, J.R. Traynor, and J.H. Woods Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats J. Pharmacol. Exp. Ther. 309 2004 173 181
17. A.J. Kastin, E.L. Scollan, R.H. Ehrensing, A.V. Schally, and D.H. Coy Enkephalin and other peptides reduce passiveness Pharmacol. Biochem. Behav. 9 1978 515 519
18. A. Kita, K. Imano, Y. Seto, I. Yakuo, T. Deguchi, and H. Nakamura Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats Jpn. J. Pharmacol. 75 1997 337 346
19. S.S. Negus, E.R. Butelman, K.J. Chang, B. DeCosta, G. Winger, and J.H. Woods Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys J. Pharmacol. Exp. Ther. 270 1994 1025 1034
20. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J. Neurosci. 15 1995 7539 7547
21. F. Noble, J.M. Soleilhac, E. Soroca-Lucas, S. Turcaud, M.C. Fournié-Zaluski, and B.P. Roques Inhibition of the enkephalin- metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats J. Pharmacol. Exp. Ther. 261 1992 181 190
22. E.D. Pakarinen, J.H. Woods, and J. Moerschbaecher Repeated acquisition of behavioral chains in squirrel monkeys: comparison of a mu, kappa and delta opioid agonist J. Pharmacol. Exp. Ther. 272 1995 552 559
23. A. Rasmussen, L. Shi, and R.S. Duman Down-regulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock Neuropsychopharmacology 27 2002 133 142
24. A. Saitoh, Y. Kimura, T. Suzuki, K. Kawai, H. Nagase, and J. Kamei Potential anxiolytic and antidepressant-like activities of SNC80, a selective d-opioid agonist, in behavioral models of rodents J. Pharmacol. Sci. 95 2004 374 380
25. M.A. Smith, S. Makino, R. Kvetnansky, and R.M. Post Stress alters the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus J. Neurosci. 15 1995 1768 1777
26. O.C. Snead III Opiate-induced seizures: a study of μ and δ specific mechanisms Exp. Neurology 93 1986 348 358
27. J.M. Stutzmann, G.A. Böhme, B.P. Roques, and J.C. Blanchard Differential electrographic patterns for specific μ- and δ-opioid peptides in rats Eur. J. Pharmacol. 123 1986 53 59
28. P. Tejedor-Real, J.A. Micó, R. Maldonado, B.P. Roques, and J. Gibert-Rahola Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat Biol. Psychiatry 34 1993 100 107
29. P. Tejedor-Real, J.A. Micó, R. Maldonado, B.P. Roques, and J. Gibert-Rahola Implication of endogenous opioid system in the learned helplessness model of depression Pharmacol. Biochem. Behav. 52 1995 145 152
30. P. Tejedor-Real, J.A. Micó, C. Smadja, R. Maldonado, B.P. Roques, and J. Gibert-Rahola Involvement of δ-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model Eur. J. Pharmacol. 354 1998 1 7
31. M.M. Torregrossa, C. Isgor, J.E. Folk, K.C. Rice, S.J. Watson, and J.H. Woods The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats Neuropsychopharmacology 29 2004 649 659
32. F.C. Tortella Endogenous opioid peptides and epilepsy: quieting the seizing brain? Trends Pharmacol. Sci. 9 1988 366 372
33. V.A. Vaidya, and R.S. Duman Depression-emerging insights from neurobiology Br. Med. Bul. 5 2001 61 79
34. G.E. Walker, and T.L. Yaksh Studies on the effects of intrathalamically injected DADL and morphine on nociceptive thresholds and electroencephalographic activity: a thalamic δ receptor syndrome Brain Res. 383 1986 1 14